Actively Recruiting
Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos
Led by Stanford University · Updated on 2026-04-24
300
Participants Needed
1
Research Sites
1042 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.
CONDITIONS
Official Title
Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Available aneuploid or mosaic embryos
- No other acceptable embryos available
- Willing to travel to Stanford for treatment
- English language fluency
You will not qualify if you...
- Use of international donor eggs or sperm not tested according to FDA guidelines
- Living outside the United States
- Embryos with Triploidy are not eligible for transfer in this protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Stanford Fertility and Reproductive Medicine Center
Sunnyvale, California, United States, 94087
Actively Recruiting
Research Team
R
Ronit Mazzoni, MS
CONTACT
R
REI Research Coordinator
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here